Protective Role of Adiponectin in Cardiovascular Disease

Author(s): R. Shibata, T. Murohara, N. Ouchi

Journal Name: Current Medicinal Chemistry

Volume 19 , Issue 32 , 2012

Become EABM
Become Reviewer
Call for Editor


This review focuses on the recent findings that adiponectin plays a significant role of in cardiovascular diseases. Adipose tissue functions as an endocrine organ by secreting adipocytokines that can directly affect nearby or remote organs. Adiponectin is an adipocytokine whose concentration is down-regulated in subjects with obesity-related disorders. Low levels of circulating adiponectin appear to associate with the increased prevalence of obesity-linked diseases including atherosclerosis and ischemic heart disease. A number of experimental studies have shown that adiponectin exerts beneficial effects on the cardiovascular system by directly acting on the component cells in the heart and blood vessels. The cardiovascular protection by adiponectin is mediated through its ability to attenuate inflammatory responses and apoptotic activities in the target organs. Thus, adiponectin could represent a therapeutic target molecule for prevention or treatment of cardiovascular diseases.

Keywords: Adiponectin, atherosclerosis, coronary artery disease, ischemic heart disease, inflammation, "cardiovascular diseases", Adipos Tissues, "endocrine organ", "herosclerosis", "schemic heart disease"

open access plus

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2012
Published on: 30 October, 2012
Page: [5459 - 5466]
Pages: 8
DOI: 10.2174/092986712803833164

Article Metrics

PDF: 34